1-Methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide, 95.0%, 250mg

3,4-Diaminobenzimidamide hydrochloride, 98% HPLC, 1g

(R)-(2-Methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazol-2-yl)methanol, 97%, 250mg

(R)-3-Benzylmorpholine, 95.0%, 1g

4-Amino-3-fluorophenol, 99.00%, 100g

1,2,3,4-TETRAHYDROQUINOLINE-2-CARBOXYLIC ACID HCL, 97.0%, 5g

(R)-methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate, 95%, 100mg

2'-Methylbiphenyl-4-carboxylic acid, 95.0%, 1g

METHYL 2-AMINO-2-PHENYLPROPIONATE, 95%, 1g

3,11-Dichloro-6,11-dihydro-6-methyl-5,5-dioxodibenzo[c,f][1,2]thiazepine, 95.0%, 25g

Flat flange reaction vial DURAN®, DN 60, 100 ml, 100 mm, 70 mm, Height, 85 mm, 1 Piece

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(thiophen-3-yl)propanoic acid, 95.0%, 250mg

(S)-Methyl morpholine-2-carboxylate hydrochloride, 95.0%, 5g